Publication date: Feb 14, 2018 Pregnant women with multiple sclerosis (MS) exposed to Tysabri (natalizumab) in the first trimester had higher rates of miscarriage and major birth defects in their ... Read more

Publication date: Sep 17, 2019 Continuing Tysabri (natalizumab) treatment up to week 28 of pregnancy, and restarting soon after birth, reduces the risk of relapses in women with multiple sclerosis ... Read more

Publication date: Sep 11, 2019 While pregnancy does not appear to affect the disease course of multiple sclerosis (MS), questions remain about the best time to stop or resume treatment ... Read more

Publication date: Jul 30, 2019 The European Medicines Agency (EMA) has recommended that the multiple sclerosis medicine Gilenya (fingolimod) must not be used in pregnant women and in women able ... Read more

Publication date: Aug 30, 2019 Aubagio can cause mild or serious side effects. The following list contains some of the key side effects that may occur while taking Aubagio. For ... Read more

Publication date: Aug 30, 2019 Aubagio can cause mild or serious side effects. The following list contains some of the key side effects that may occur while taking Aubagio. For ... Read more

Publication date: Aug 30, 2019 Aubagio can cause mild or serious side effects. The following list contains some of the key side effects that may occur while taking Aubagio. For ... Read more